top of page

Press Releases

Ordinateur portable et paperasse

16 nov. 2023

IMPLANET receives the approval of its shareholders for its planned capital increase

31 oct. 2023

IMPLANET specifies the terms of its planned capital increase

17 oct. 2023

IMPLANET announces its 3rd-quarter and 9-month revenue to September 30, 2023

11 oct. 2023

IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue

28 sept. 2023

IMPLANET signs an agreement with Sanyou Medical for a proposed capital increase with preferential subscription rights

28 sept. 2023

IMPLANET publishes its 2023 half-year results

11 juil. 2023

IMPLANET reports revenue of €4.3 million in the first half of 2023

4 mai 2023

Minutes of Implanet’s Annual General Meeting held on May 3, 2023

25 avr. 2023

IMPLANET reports its Q1 2023 revenue

11 avr. 2023

IMPLANET receives FDA clearance for its Squale anterior cervical cage range

7 mars 2023

IMPLANET reports its 2022 financial results

24 janv. 2023

IMPLANET reports 2022 annual revenue of €8.0 million, up 31%

14 déc. 2022

2023 Financial Calendar

28 nov. 2022

IMPLANET signs an exclusive distribution contract for SMTP Technology Co.'s ultrasonic surgical scalpel in France

16 nov. 2022

IMPLANET signs a distribution agreement with Sanyou Medical in China and a technological partnership for the development of a new product range

26 oct. 2022

IMPLANET announces 9-month revenue of €6 million as of September 30, 2022, up +37%

20 oct. 2022

Implanet announces the success of its capital increase

28 sept. 2022

Launch of an issue of shares with warrants with preferential subscription rights

20 sept. 2022

IMPLANET publishes its 2022 half-year results

20 sept. 2022

Partnership with Sanyou Medical: conditions precedent fulfilled

11 juil. 2022

IMPLANET reports its revenue for Q2 2022, up 33%

29 juin 2022

Implanet announces a commercial, technological and financial partnership with Sanyou Medical, a Chinese manufacturer of medical devices for spine surgery

19 avr. 2022

IMPLANET reports Q1 2022 revenue

15 mars 2022

IMPLANET reports its 2021 financial results and reviews its transformative year

22 févr. 2022

IMPLANET announces the first surgical operations in the United States with the ORIGIN cervical plate

10 févr. 2022

IMPLANET announces the first surgical procedures in the United States with JAZZ PF

27 janv. 2022

IMPLANET announces 2021 revenue growth of 58%, under IFRS

2 nov. 2021

IMPLANET announces the divestment of its knee prosthesis range to refocus on its Spine business

12 oct. 2021

IMPLANET reports consolidated revenue of €5.8 million at September 30, 2021 up 34%

23 sept. 2021

Implanet announces the planned divestment of its knee prosthesis to focus on its Spine business

21 sept. 2021

IMPLANET reports an improvement in its 2021 half-year results

6 juil. 2021

IMPLANET announces consolidated revenue of €2.04 million for Q2 2021

22 juin 2021

IMPLANET signs a strategic partnership with ulrich medical for the distribution of its JAZZ implants and the OSD cervical plate

15 juin 2021

IMPLANET signs an exclusive distribution contract for France with GLOBUS MEDICAL

18 mai 2021

IMPLANET announces the implementation of the OSD acquisition

5 mai 2021

Second call of Implanet's AGM on 18 May 2021 at 14:00

20 avr. 2021

Implanet reports Q1 2021 revenue of €1.7 million, driven by the dramatic growth of its Spine activity

15 avr. 2021

Procedures for participating in Implanet's Combined General Meeting of May 5, 2021 at 2 pm CEST

12 avr. 2021

Implanet receives TGA clearance for the MADISON total knee prosthesis in Australia

31 mars 2021

Holding of Implanet's AGM on May 5, 2021 at 2 pm CEST

30 mars 2021

Implanet finalizes the agreement to acquire OSD, a manufacturer of implants for spine surgery, to create a new benchmark player

17 mars 2021

Implanet confirms offer to acquire a majority stake in Orthopaedic & Spine Development

18 févr. 2021

Implanet reports an improvement in its 2020 results

19 janv. 2021

Implanet announces 2020 revenue of €6 million

13 janv. 2021

Implanet enters into exclusive negotiations for the acquisition of a European manufacturer of implants for spine surgery, and signs a financing

6 janv. 2021

Implanet announces its 2021 financial calendar

4 nov. 2020

Implanet signs distribution agreement for its JAZZ platform products in Mexico

19 oct. 2020

Implanet and SeaSpine announce FDA clearance of the Mariner Cap System

13 oct. 2020

Implanet reports revenue of €1.75 million for Q3 2020, marking the resumption of surgeries in France and abroad

22 sept. 2020

Implanet to participate in the SFCR Annual Conference

bottom of page